Resistance to antiretroviral drugs in patients with primary HIV-1 infection
- 31 December 2000
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 16 (4), 429-434
- https://doi.org/10.1016/s0924-8579(00)00270-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsNew England Journal of Medicine, 1998
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Virological and clinical implications of resistance to HIV-1 protease inhibitors.Drug Resistance Updates, 1998
- Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine TreatmentThe Journal of Infectious Diseases, 1995
- Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitorsNature Structural & Molecular Biology, 1995
- Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.Proceedings of the National Academy of Sciences, 1993
- Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1993
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989